[HTML][HTML] Clinical characteristics of coronavirus disease 2019 in China

…, C Ou, J He, L Liu, H Shan, C Lei… - New England journal …, 2020 - Mass Medical Soc
Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in
Wuhan city and rapidly spread throughout China, data have been needed on the clinical …

Increasing solar absorption for photocatalysis with black hydrogenated titanium dioxide nanocrystals

X Chen, L Liu, PY Yu, SS Mao - Science, 2011 - science.org
When used as a photocatalyst, titanium dioxide (TiO 2 ) absorbs only ultraviolet light, and
several approaches, including the use of dopants such as nitrogen, have been taken to narrow …

Isokinetic relationship, isoequilibrium relationship, and enthalpy− entropy compensation

L Liu, QX Guo - Chemical reviews, 2001 - ACS Publications
Lei LiuLei Liu, born in 1977 in Chuzhou, China, received his BS degree in Chemistry
with honors from the University of Science and Technology of China (USTC). From 1996 to …

[HTML][HTML] Black titanium dioxide (TiO 2) nanomaterials

X Chen, L Liu, F Huang - Chemical Society Reviews, 2015 - pubs.rsc.org
In the past few decades, there has been a wide research interest in titanium dioxide (TiO2)
nanomaterials due to their applications in photocatalytic hydrogen generation and …

[HTML][HTML] Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

…, J Xiang, Y Hu, L Liu, H Shan, C Lei… - European …, 2020 - Eur Respiratory Soc
Background The coronavirus disease 2019 (COVID-19) outbreak is evolving rapidly worldwide.
Objective To evaluate the risk of serious adverse outcomes in patients with COVID-19 by …

Treatment of 5 critically ill patients with COVID-19 with convalescent plasma

…, F Chen, K Huang, Y Jiang, D Liu, Z Zhang, Y Liu, L Liu - Jama, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) is a pandemic with no specific therapeutic
agents and substantial mortality. It is critical to find new treatments. Objective To determine …

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

Y Liu, Y Yang, C Zhang, F Huang, F Wang… - Science China Life …, 2020 - Springer
The outbreak of the 2019-nCoV infection began in December 2019 in Wuhan, Hubei province,
and rapidly spread to many provinces in China as well as other countries. Here we report …

Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019

J Zhao, Q Yuan, H Wang, W Liu, X Liao… - Clinical infectious …, 2020 - academic.oup.com
Background The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody
response in infected patients remains largely unknown, and the clinical value of antibody …

[HTML][HTML] Clinical characteristics of 2019 novel coronavirus infection in China

…, Z Ni, Y Hu, W Liang, C Ou, J He, L Liu, H Shan, C Lei… - MedRxiv, 2020 - medrxiv.org
Background Since December 2019, acute respiratory disease (ARD) due to 2019 novel
coronavirus (2019-nCoV) emerged in Wuhan city and rapidly spread throughout China. We …

[HTML][HTML] Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

M Liao, Y Liu, J Yuan, Y Wen, G Xu, J Zhao, L Cheng… - Nature medicine, 2020 - nature.com
Respiratory immune characteristics associated with Coronavirus Disease 2019 (COVID-19)
severity are currently unclear. We characterized bronchoalveolar lavage fluid immune cells …